Prognostic value of serum progesterone and LH values on the day of hCG administration in IUI GnRH antagonist cycles

References

• Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990;5:357–376.
   PubMed Web of Science ®Google Scholar
• Barlow DH. GnRH agonists and in vitro fertilization. J Reprod Med 1998;43:245–251.
   PubMed Web of Science ®Google Scholar
• Shapiro DB, Mitchell-Leef D. GnRH antagonist in in vitro fertilization: where we are now. Minerva Ginecol 2003;55:373–388.
   PubMedGoogle Scholar
• Venetis CA, Kolibianakis EM, Papanikolaou E, Bontis J, Devroey P, Tarlatzis BC. Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. Hum Reprod Update 2007;13:343–355.
   PubMed Web of Science ®Google Scholar
• Matorras R, Ramón O, Expósito A, Corcóstegui B, Ocerin I, Gonzalez-Lopera S, Rodríguez-Escudero FJ. Gn-RH antagonists in intrauterine insemination: the weekend-free protocol. J Assist Reprod Genet 2006;23:51–54.
   PubMed Web of Science ®Google Scholar
• Lambalk CB, Leader A, Olivennes F, Fluker MR, Andersen AN, Ingerslev J, Khalaf Y, et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 2006;21:632–639.
   PubMed Web of Science ®Google Scholar
• Kosmas IP, Tatsioni A, Kolibianakis EM, Verpoest W, Tournaye H, Van der Elst J et al., 2007. Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. Fertil Steril;87:607–612.
   PubMed Web of Science ®Google Scholar
• Ramón O, Matorras R, Corcóstegui B, Meabe A, Burgos J, Expósito A, Crisol L. Ultrasound-guided artificial insemination: a randomized controlled trial. Hum Reprod 2009;24:1080–1084.
   PubMed Web of Science ®Google Scholar
• Matorras R, Pérez C, Corcóstegui B, Pijoan JI, Ramón O, Delgado P, Rodríguez-Escudero FJ. Treatment of the male with follicle-stimulating hormone in intrauterine insemination with husband’s spermatozoa: a randomized study. Hum Reprod 1997;12:24–28.
   PubMed Web of Science ®Google Scholar
• Osuna C, Matorras R, Pijoan JI, Rodríguez-Escudero FJ. One versus two inseminations per cycle in intrauterine insemination with sperm from patients’ husbands: a systematic review of the literature. Fertil Steril 2004;82:17–24.
   PubMed Web of Science ®Google Scholar
• Matorras R, Diaz T, Corcostegui B, Ramón O, Pijoan JI, Rodriguez-Escudero FJ. Ovarian stimulation in intrauterine insemination with donor sperm: a randomized study comparing clomiphene citrate in fixed protocol versus highly purified urinary FSH. Hum Reprod 2002;17:2107–2111.
   PubMed Web of Science ®Google Scholar
• Manzi DL, Dumez S, Scott LB, Nulsen JC. Selective use of leuprolide acetate in women undergoing superovulation with intrauterine insemination results in significant improvement in pregnancy outcome. Fertil Steril 1995;63:866–873.
   PubMed Web of Science ®Google Scholar
• Cantineau AE, Cohlen BJ, Heineman MJ. Ovarian stimulation protocols (anti-oestrogens, gonadotrophins with and without GnRH agonists/antagonists) for intrauterine insemination (IUI) in women with subfertility. Cochrane Database Syst Rev 2007; CD005356.
   PubMed Web of Science ®Google Scholar
• Dodson WC, Walmer DK, Hughes CL Jr, Yancy SE, Haney AF. Adjunctive leuprolide therapy does not improve cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination of subfertile women. Obstet Gynecol 1991;78:187–190.
   PubMed Web of Science ®Google Scholar
• Sengoku K, Tamate K, Takaoka Y, Morishita N, Ishikawa M. A randomized prospective study of gonadotrophin with or without gonadotrophin-releasing hormone agonist for treatment of unexplained infertility. Hum Reprod 1994;9:1043–1047.
   PubMed Web of Science ®Google Scholar
• Williams RS, Hillard JB, De Vane G, Yeko T, Kipersztok S, Rhoton-Vlasak A, Sistrom C. A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol 2004;191:648–51; discussion 651.
   Web of Science ®Google Scholar
• Gómez-Palomares JL, Juliá B, Acevedo-Martín B, Martínez-Burgos M, Hernández ER, Ricciarelli E. Timing ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod 2005;20:368–372.
   PubMed Web of Science ®Google Scholar
• Checa MA, Prat M, Robles A, Carreras R. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertil Steril 2006;85:573–577.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Somigliana E; Intrauterine Insemination Study Group. Effect of GnRH antagonists in FSH mildly stimulated intrauterine insemination cycles: a multicentre randomized trial. Hum Reprod 2007;22:500–505.
   PubMed Web of Science ®Google Scholar
• Allegra A, Marino A, Coffaro F, Scaglione P, Sammartano F, Rizza G, Volpes A. GnRH antagonist-induced inhibition of the premature LH surge increases pregnancy rates in IUI-stimulated cycles. A prospective randomized trial. Hum Reprod 2007;22:101–108.
   PubMed Web of Science ®Google Scholar
• Mitwally MF, Abdel-Razeq S, Casper RF. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination. Reprod Biol Endocrinol 2004;2:55.
   PubMedGoogle Scholar
• Lee TH, Lin YH, Seow KM, Hwang JL, Tzeng CR, Yang YS. Effectiveness of cetrorelix for the prevention of premature luteinizing hormone surge during controlled ovarian stimulation using letrozole and gonadotropins: a randomized trial. Fertil Steril 2008;90:113–120.
   PubMed Web of Science ®Google Scholar
• Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J, Pellicer A. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:1444–1449.
   PubMed Web of Science ®Google Scholar
• Martínez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, Barri PN, Balasch J. Serum progesterone concentrations on the day of HCG administration cannot predict pregnancy in assisted reproduction cycles. Reprod Biomed Online 2004;8:183–190.
   PubMed Web of Science ®Google Scholar
• Hofmann GE, Bentzien F, Bergh PA, Garrisi GJ, Williams MC, Guzman I, Navot D. Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril 1993;60:675–679.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Righini C, Olivennes F, Taieb J, de Ziegler D, Frydman R. Computerized assessment of endometrial echogenicity: clues to the endometrial effects of premature progesterone elevation. Fertil Steril 1999;71:174–181.
   PubMed Web of Science ®Google Scholar
• Melo MA, Meseguer M, Garrido N, Bosch E, Pellicer A, Remohí J. The significance of premature luteinization in an oocyte-donation programme. Hum Reprod 2006;21:1503–1507.
   PubMed Web of Science ®Google Scholar